Gines Diego Miralles - 14 Mar 2025 Form 4 Insider Report for Contineum Therapeutics, Inc. (CTNM)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CTNM	Stock Option (right to buy)	Award	$0	+29,500		$0.000000	29,500	14 Mar 2025	Class A Common Stock	29,500	$6.67	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Options granted under the Issuer's 2024 Equity Incentive Plan, pursuant to the Issuer's Non-Employee Director Compensation Program, as amended. One-third of the option shares vest on March 14, 2026, and the remainder vests in 24 equal monthly installments thereafter, subject to the Reporting Person's continuous service.